🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Naveen Garg

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-0321-2813

Also affiliated with Centre of Biomedical Research

Health ProfessionsEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer”.

Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer

Annals of Surgery(2023)10.1097/sla.0000000000005878

N/A

1.5DataRank · unranked

43 citations

Nathan H. Parker, Lianchun Xiao, Keri Schadler, Maria Q. B. Petzel, Laura R. Prakash +18 more

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001009

N/A

0.606DataRank · unranked

56 citations

Kevin C. Miller, Lina Altameemi, M. Shaaban Ali, Sameh Nassar, Naveen Garg +10 more

Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer

Journal of Gastrointestinal Oncology(2022)10.21037/jgo-21-471

N/A

0.241DataRank · unranked

4 citations

Bryan K. Kee, Michael J. Overman, Arvind Dasari, Kanwal Raghav, Benny Johnson +6 more

New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity

Haematologica(2020)10.3324/haematol.2019.235804

N/A

0DataRank · unranked

18 citations

Behrang Amini, Ethan B. Ludmir, Jillian R. Gunther, Sarah A. Milgrom, Chelsea C. Pinnix +15 more

Ibrutinib, Fludarabine, Cyclophosphamide and Obinutuzumab (iFCG) for Firstline Treatment of Patients with CLL with Mutated IGHV and without Del(17p)/ TP53 Mutation: Six-Year Follow-up Analyses

Blood(2023)10.1182/blood-2023-188084

N/A

0DataRank · unranked

1 citations

Philip A. Thompson, Akhil Jain, Jan A. Burger, Alessandra Ferrajoli, Jayastu Senapati +27 more

Automated Spontaneous Echo Contrast Detection Using a Multisequence Attention Convolutional Neural Network

Ultrasound in Medicine & Biology(2024)10.1016/j.ultrasmedbio.2024.01.016

N/A

0DataRank · unranked

3 citations

Zewei Shi, Naveen Garg, Corey T. Jensen, Mark L. Palmeri, Ouwen Huang

Early Obinutuzumab Significantly Increases Bone Marrow Undetectable MRD (10-4 sensitivity) (uMRD4) Rate When Combined with Acalabrutinib and Venetoclax in a Randomized Phase II Trial for Treatment Naïve CLL

Blood(2024)10.1182/blood-2024-211110

N/A

0DataRank · unranked

2 citations

Philip A. Thompson, Jan A. Burger, Musa Yılmaz, Nitin B. Jain, Tapan M. Kadia +23 more